menu
    • menu

    Company profile for Soligenix

    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Soligenix has specialized knowledge in the development of orphan and unmet medical need indications including preclinical, manufacturing, regulatory and clinical expertise. We are a late-stage biopharmaceutical company committed to developing and commercializing products to treat rare diseases where there is an unmet medical need. Soligenix has a number of Public Health programs, funded entirely by government grants and contra...
    Soligenix has specialized knowledge in the development of orphan and unmet medical need indications including preclinical, manufacturing, regulatory and clinical expertise. We are a late-stage biopharmaceutical company committed to developing and commercializing products to treat rare diseases where there is an unmet medical need. Soligenix has a number of Public Health programs, funded entirely by government grants and contracts, which focus on infectious disease and biodefense applications, including our most advanced vaccination program to prevent ricin poisoning.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SoligenixUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    29 Emmons Drive Suite B-10 Princeton, NJ 08540
    Telephone
    Telephone
    609-538-8200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.soligenix.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/soligenix-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Soligenix_Inc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SGX945 Phase 2 Trial Shows Promising Results In Behçet's Disease
    SGX945 Phase 2 Trial Shows Promising Results In Behçet's Disease

    18 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/positive-clinical-results-from-phase-2-trial-of-sgx945-for-the-treatment-of-behcets-disease-published-in-rheumatology-oxford-302645452.html

    PR NEWSWIRE
    18 Dec 2025
    Share Share
    Soligenix Announces Top-line Results of the Ph 2a Study of SGX302
    Soligenix Announces Top-line Results of the Ph 2a Study of SGX302

    17 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/soligenix-announces-top-line-results-of-the-phase-2a-study-of-sgx302-synthetic-hypericin-in-patients-with-mild-to-moderate-psoriasis-302644314.html

    PR NEWSWIRE
    17 Dec 2025
    Share Share
    Soligenix Advancing Rare-Disease Positioned at Pivotal Crossroad
    Soligenix Advancing Rare-Disease Positioned at Pivotal Crossroad

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200703/0/en/Soligenix-Inc-NASDAQ-SNGX-Advancing-Rare-Disease-Therapies-Positioned-at-Pivotal-Crossroad.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    Breakthrough Therapies Rise as Rare Diseases Burden Aging
    Breakthrough Therapies Rise as Rare Diseases Burden Aging

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3199778/0/en/Breakthrough-Therapies-Advance-as-Rare-Disease-Burden-Intensifies-Across-Aging-Populations.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    Soligenix's Innovative Platform Revolutionizes Treatment for CTCL
    Soligenix's Innovative Platform Revolutionizes Treatment for CTCL

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198880/0/en/Soligenix-Inc-NASDAQ-SNGX-Innovative-Platform-Provides-Novel-Treatment-for-Underserved-CTCL-Space.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    HyBryte Targets Rare Diseases in Aging America
    HyBryte Targets Rare Diseases in Aging America

    02 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/02/3197947/0/en/Chronic-Rare-Diseases-in-an-Aging-America-Why-HyBryte-and-Federal-Policy-Matter-Now.html

    GLOBENEWSWIRE
    02 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search